In-Silico Drug discovery approach targeting receptor tyrosine kinase-like orphan receptor 1 for cancer treatment
- PMID: 28432357
- PMCID: PMC5430761
- DOI: 10.1038/s41598-017-01254-w
In-Silico Drug discovery approach targeting receptor tyrosine kinase-like orphan receptor 1 for cancer treatment
Abstract
Receptor tyrosine kinases (RTK) are important cell signaling molecules that influence many cellular processes. Receptor tyrosine kinase such as orphan receptor 1 (Ror1), a surface antigen, is a member of the RTK family of Ror, which plays a crucial role in cancers that have high-grade histology. As Ror1 has been implicated to be a potential target for cancer therapy, we selected this protein for further investigation. The secondary and tertiary structure of this protein was determined, which revealed that this protein contained three β-sheets, seven α-helices, and coils. The prediction of the active site revealed its cage-like function that opens for ligand entry and then closes for interacting with the ligands. Optimized ligands from the database were virtually screened to obtain the most efficient and potent ones. The screened ligands were evaluated for their therapeutic usefulness. Furthermore, the ligands that passed the test were docked to the target protein resulting in a few ligands with high score, which were analyzed further. The highest scoring ligand, Beta-1, 2,3,4,6-Penta-O-Galloyl-D-Glucopyranose was reported to be a naturally occurring tannin. This in silico approach indicates the potential of this molecule for advancing a further step in cancer treatment.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures









Similar articles
-
Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment.J Med Chem. 2024 Jul 11;67(13):10655-10686. doi: 10.1021/acs.jmedchem.4c00175. Epub 2024 Jun 24. J Med Chem. 2024. PMID: 38913699
-
In-silico identification of inhibitors against mutated BCR-ABL protein of chronic myeloid leukemia: a virtual screening and molecular dynamics simulation study.J Biomol Struct Dyn. 2016 Oct;34(10):2171-83. doi: 10.1080/07391102.2015.1110046. Epub 2016 Jan 8. J Biomol Struct Dyn. 2016. PMID: 26479578
-
Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach.Mol Divers. 2022 Aug;26(4):1933-1955. doi: 10.1007/s11030-021-10304-5. Epub 2021 Sep 23. Mol Divers. 2022. PMID: 34554395
-
Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells.Expert Opin Ther Targets. 2019 May;23(5):447-456. doi: 10.1080/14728222.2019.1602608. Epub 2019 Apr 20. Expert Opin Ther Targets. 2019. PMID: 30935250 Review.
-
The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.Semin Cancer Biol. 2014 Dec;29:21-31. doi: 10.1016/j.semcancer.2014.07.005. Epub 2014 Jul 25. Semin Cancer Biol. 2014. PMID: 25068995 Review.
Cited by
-
Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway.Int J Mol Sci. 2024 Jun 26;25(13):7003. doi: 10.3390/ijms25137003. Int J Mol Sci. 2024. PMID: 39000112 Free PMC article.
-
Integration of Ligand-Based and Structure-Based Methods for the Design of Small-Molecule TLR7 Antagonists.Molecules. 2022 Jun 23;27(13):4026. doi: 10.3390/molecules27134026. Molecules. 2022. PMID: 35807273 Free PMC article.
-
Targeting dual specificity protein kinase TTK attenuates tumorigenesis of glioblastoma.Oncotarget. 2017 Dec 11;9(3):3081-3088. doi: 10.18632/oncotarget.23152. eCollection 2018 Jan 9. Oncotarget. 2017. PMID: 29423030 Free PMC article.
-
Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors.Comput Struct Biotechnol J. 2019 Feb 10;17:291-310. doi: 10.1016/j.csbj.2019.02.006. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 30867893 Free PMC article.
-
How to Cope with the Challenges of Environmental Stresses in the Era of Global Climate Change: An Update on ROS Stave off in Plants.Int J Mol Sci. 2022 Feb 11;23(4):1995. doi: 10.3390/ijms23041995. Int J Mol Sci. 2022. PMID: 35216108 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials